Pure Brands
Leadership in Regulated Psychedelic Solutions.
Developing innovative therapeutics for trauma care paired with pharmaceutical-grade alternatives for harm reduction backed by Health Canada.
Our Approach
Pure Brands bridges innovation with pharmaceutical excellence. Our good manufacturing practices (GMP) compliant facility (certification pending) and Health Canada authorization for six controlled substances enable end-to-end development — from API processing to finished therapeutics. We combine rigorous manufacturing standards with innovative delivery methods to create treatments that offer precise dosing, safety, and accessibility. Every step, from research through production, is guided by our commitment to transforming trauma care through regulated, pharmaceutical-grade psychedelic therapeutic solutions.
Supporting Those Who Serve
Veterans and first responders face unique trauma-related challenges. Pure Brands is developing specialized psychedelic therapeutics designed specifically for PTSD, treatment-resistant depression, and complex trauma. Working closely with veteran advocacy groups and clinical partners, we're committed to ensuring accessible, effective treatment options for those who need them most.
Our Facility
Our 4,500 sq ft facility stands as one of Canada's premier controlled substance operations. With dedicated zones for research, manufacturing, and quality control, we've created an environment where innovation thrives within the highest safety and security standards. This unique infrastructure positions Pure Brands at the forefront of regulated psychedelic pharmaceutical development.
Our Services
-
Partnerships
-
Prescriptions
-
Formulations
-
Quality Testing